Dr. Vasileios John Assikis, MD

Dr. Assikis practices at Piedmont West Ambulatory Surgery Center in Atlanta, Georgia.

Dr. Assikis' NPI, 1730147596, was assigned on May 2, 2006. Dr. Assikis graduated from Aristotle University of Thessaloniki School of Medicine in 1991. Dr. Assikis' Georgia license number on file is 052530.

Dr. Assikis' primary practice is Piedmont West Ambulatory Surgery Center, at 1800 Howell Mill NW Rd, Atlanta, GA 30318 in Fulton County. The practice phone is (404) 317-2694.

Dr. Assikis' primary practice is Piedmont West Ambulatory Surgery Center in Atlanta, Georgia. Dr. Assikis is also affiliated with Piedmont Atlanta. The medical group on file is Piedmont Cancer Institute. Dmand AI also links Dr. Assikis to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Assikis practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Assikis' primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Assikis is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Dr. Assikis' licenses on file in 3 states: Georgia, Texas and Illinois.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, fluid and electrolyte imbalances, immune deficiency disease, lung cancer and lymphoma among the conditions Dr. Assikis treats.

CMS data shows 120,837 Medicare services from Dr. Assikis across 45 procedure codes in 2024, for 830 Medicare patients. Medicare paid $2,866,164 for them.

CMS counts 830 Medicare patients who saw Dr. Assikis in 2024. The largest group is 65 to 74, with 335 patients. 75% of them have high blood pressure, and 69% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.93, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Assikis' median patient age at 69, with 55% women.

In 2024, Dr. Assikis wrote 3,558 Medicare Part D claims for 475 patients. 69% of them were for generic drugs. CMS names the drug for 3,225 of them, across 65 drugs with 11 or more claims each, at $10,689,135 in total drug cost. In 2023, CMS named 2,806 claims across 59 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Assikis for performance year 2024, reported as part of a group. CMS lists Dr. Assikis as offering telehealth.

Dmand AI links 4 papers to Dr. Assikis, published from 2011 to 2021. 2011 was the busiest year, with 2. The most frequent topics are Neoplasm Metastasis, Prostatic Neoplasms, Castration-Resistant and Quinolines. Dr. Assikis has published most often in J Clin Oncol. Dr. Assikis' most frequent co-authors are Michael Anthony Carducci, MD, Roberto Pili, MD and Andrew John Armstrong, MD.

Dmand AI links Dr. Assikis to 7 clinical trials, 3 of them phase 1/2 studies. 1 is still active or recruiting. Conditions studied include Pancreatic Neoplasms, Pancreatic Diseases and Breast Neoplasms.

CMS Open Payments shows 508 general payments to Dr. Assikis from 59 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 41% of the total. Myovant Sciences Inc. paid the most, $10,891. It also lists 2 research payments totaling $1,270 in 2025.

Dmand AI lists 2 awards for Dr. Assikis, most recently Atlanta Magazine: Top Doctors in 2014.

Dr. Assikis graduated from Aristotle University of Thessaloniki School of Medicine in 1991.

Dr. Assikis is in network with 17 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.